Published in Drug Week, November 15th, 2002
A professional point-of-care skin cholesterol test system, IMI's Cholesterol 1,2,3 is cleared for sale in the U.S., Europe, and Canada.
In the trial IMI is evaluating two different products that were developed with input from the company's Canadian marketing partner, McNeil Consumer Healthcare. Both tests feature a simplified test procedure suitable for the consumer market. One test design involves placing the fingertip on a test strip that changes color to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.